Total Payments
$1,502
2024 Payments
$132.28
Companies
14
Transactions
69
Medicare Patients
3,069
Medicare Billing
$381,404
Payment Breakdown by Category
Food & Beverage$1,502 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,502 | 69 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $845.90 | 36 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $155.52 | 8 | $0 (2023) |
| NESTLE HEALTHCARE NUTRITION INC. | $129.88 | 7 | $0 (2023) |
| Braintree Laboratories, Inc. | $59.83 | 3 | $0 (2021) |
| Merck Sharp & Dohme LLC | $44.86 | 2 | $0 (2024) |
| Janssen Biotech, Inc. | $44.28 | 2 | $0 (2023) |
| PFIZER INC. | $40.00 | 2 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $36.64 | 2 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $35.64 | 2 | $0 (2021) |
| GENZYME CORPORATION | $28.79 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $132.28 | 6 | ABBVIE INC. ($68.42) |
| 2023 | $198.05 | 9 | ABBVIE INC. ($56.92) |
| 2022 | $530.07 | 23 | ABBVIE INC. ($416.66) |
| 2021 | $452.85 | 22 | AbbVie Inc. ($247.87) |
| 2020 | $56.03 | 2 | AbbVie Inc. ($56.03) |
| 2019 | $46.77 | 2 | Braintree Laboratories, Inc. ($26.22) |
| 2018 | $28.57 | 2 | Ferring Pharmaceuticals Inc. ($17.13) |
| 2017 | $57.86 | 3 | Valeant Pharmaceuticals North America LLC ($23.86) |
All Payment Transactions
69 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 06/18/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/20/2024 | ABBVIE INC. | HUMIRA (Biological), RINVOQ | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: IMMUNOLOGY | ||||||
| 03/26/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: IMMUNOLOGY | ||||||
| 03/22/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $28.28 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/24/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/30/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.79 | General |
| Category: Immunology | ||||||
| 09/14/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/28/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 08/08/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/27/2023 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $20.35 | General |
| Category: THERAPY FOR CSID | ||||||
| 06/06/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: IMMUNOLOGY | ||||||
| 04/14/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Immunology | ||||||
| 04/03/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 03/24/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $29.63 | General |
| Category: IMMUNOLOGY | ||||||
| 09/08/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: IMMUNOLOGY | ||||||
| 09/08/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $0.85 | General |
| Category: IMMUNOLOGY | ||||||
| 08/24/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $29.57 | General |
| Category: IMMUNOLOGY | ||||||
| 08/15/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: IMMUNOLOGY | ||||||
| 08/04/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $29.36 | General |
| Category: IMMUNOLOGY | ||||||
| 07/28/2022 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 07/21/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: IMMUNOLOGY | ||||||
| 07/19/2022 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/14/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $31.47 | General |
| Category: Immunology | ||||||
| 07/07/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $29.20 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 733 | 763 | $397,840 | $97,814 |
| 2022 | 13 | 768 | 812 | $390,390 | $92,083 |
| 2021 | 13 | 851 | 923 | $418,685 | $105,754 |
| 2020 | 14 | 717 | 802 | $346,025 | $85,753 |
Total Patients
3,069
Total Services
3,300
Medicare Billing
$381,404
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 74 | 74 | $74,000 | $15,987 | 21.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 125 | 126 | $107,100 | $11,916 | 11.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 84 | 84 | $23,655 | $11,323 | 47.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 86 | 95 | $21,800 | $10,162 | 46.6% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2023 | 11 | 11 | $27,500 | $8,900 | 32.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 54 | 55 | $17,875 | $8,274 | 46.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 75 | 78 | $58,500 | $7,455 | 12.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 32 | 32 | $18,400 | $6,643 | 36.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 48 | 63 | $12,600 | $4,522 | 35.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 31 | 31 | $9,200 | $4,374 | 47.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 52 | 52 | $11,960 | $4,043 | 33.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 35 | 35 | $5,250 | $1,735 | 33.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $7,800 | $1,392 | 17.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 14 | $2,200 | $1,089 | 49.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 88 | 88 | $88,000 | $19,139 | 21.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 107 | 107 | $29,960 | $12,812 | 42.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 122 | 123 | $104,550 | $10,846 | 10.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 61 | 62 | $20,150 | $10,654 | 52.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 81 | 94 | $21,150 | $8,990 | 42.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 77 | 79 | $59,250 | $7,947 | 13.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 23 | 23 | $13,225 | $4,812 | 36.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 71 | 71 | $16,330 | $4,461 | 27.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 31 | 31 | $7,775 | $4,455 | 57.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 45 | 69 | $12,300 | $4,420 | 35.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 20 | 20 | $12,000 | $2,182 | 18.2% |
About Dr. Eugene Lee, MD
Dr. Eugene Lee, MD is a Specialist healthcare provider based in San Mateo, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023049590.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eugene Lee, MD has received a total of $1,502 in payments from pharmaceutical and medical device companies, with $132.28 received in 2024. These payments were reported across 69 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,502).
As a Medicare-enrolled provider, Lee has provided services to 3,069 Medicare beneficiaries, totaling 3,300 services with total Medicare billing of $381,404. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location San Mateo, CA
- Active Since 07/05/2006
- Last Updated 02/21/2008
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1023049590
Products in Payments
- HUMIRA (Biological) $323.33
- ZENPEP (Drug) $129.88
- CREON (Drug) $128.53
- SKYRIZI (Biological) $127.80
- ENTYVIO (Biological) $120.62
- RINVOQ (Biological) $120.14
- MAVYRET (Drug) $56.22
- DIFICID (Drug) $44.86
- XELJANZ (Drug) $40.00
- CLENPIQ (Drug) $36.64
- LINZESS (Drug) $34.96
- STELARA (Biological) $31.47
- VIBERZI (Drug) $29.55
- DUPIXENT (Biological) $28.79
- SUPREP BOWEL PREP (Drug) $26.22
- TRULANCE (Drug) $24.20
- UCERIS (Drug) $23.86
- OCALIVA (Drug) $21.26
- Entyvio (Biological) $20.55
- Sucraid (Drug) $20.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in San Mateo
Dennis Park, M.d, M.D
Specialist — Payments: $10,426
Specialist $10,426
Dr. Maryam Arjomand, M.d, M.D
Specialist — Payments: $1,861
Specialist $1,861
Dr. Paul Hazelrig, M.d, M.D
Specialist — Payments: $1,719
Specialist $1,719
Dr. Edward Onuma, M.d.,Phd, M.D.,PHD
Specialist — Payments: $957.08
Specialist $957.08
Timothy Offensend, Md, MD
Specialist — Payments: $822.90
Specialist $822.90
Marna Skaar, M.d, M.D
Specialist — Payments: $739.73
Specialist $739.73